Supplementary Fig. S3 from Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Fig.S3 shows efficacy of CIDD-0149897 combination therapy.
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4388111997
